Humacyte Appoints Chris Fang Chief Medical Officer

Regenerative medicine company Humacyte has appointed Chris Fang to serve as chief medical officer. Fang comes to the Research Triangle Park, NC, company from Amaris Health, where he was managing partner. His experience also includes posts at Johnson & Johnson (NYSE: [[ticker:JNJ]]), Medtronic (NYSE: [[ticker:MDT]]), and Mitsubishi Pharma. Humacyte has developed a way to produce blood vessels in a lab that can offer an alternative to synthetic implants for patients with blood flow problems.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.